International Companies

Weaker sales of key drugs leads to mixed quarter for Novartis

By Josh White

Date: Tuesday 29 Oct 2024

(Sharecast News) - Novartis reported a mixed third quarter on Tuesday, as the pharmaceutical giant lifted its profit outlook for the year but faced disappointing sales in key areas.
Its shares were in the red in early Swiss trading due to weaker-than-expected sales of its heart failure drug, Entresto, and a...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page